Aurobindo bids $1.6B for Novartis' U.S. dermatology generics: report

7th May 2018 Uncategorised 0

India’s Aurobindo has submitted a $1.6 billion offer for Novartis’ generic dermatology assets in the U.S., according to Livemint.

More: Aurobindo bids .6B for Novartis' U.S. dermatology generics: report
Source: fierce